人类乳头瘤病毒致癌的重要决定因素有哪些?
Karl Munger1, Elizabeth A White2
1Department of Developmental, Molecular and Chemical Biology, Tufts University School of Medicine, Boston, Massachusetts, USA.
mBio
|October 4, 2024
概括
人类乳头瘤病毒 (HPV) 基蛋白E6和E7通过改变宿主细胞功能来驱动癌症. 识别关键的E6/E7标是理解HPV致癌和开发向治疗的关键.
科学领域:
- 在瘤学瘤学.
- 病毒学 病毒学
- 分子生物学分子生物学
背景情况:
- 人类乳头瘤病毒 (HPV) 是癌症的主要病毒性原因.
- HPV E6 和 E7 coproteins 操纵宿主细胞通路以促进增殖和抑制细胞死亡.
- 高风险HPVE6和E7蛋白的失调表达足以启动和维持与HPV相关的癌症.
研究的目的:
- 为了确定HPVE6和E7瘤蛋白的关键宿主细胞标,这些瘤蛋白驱动致癌.
- 区分病毒复制所必需的点和癌症发展所必需的点.
- 将抗癌疗法开发的重点放在必要的病毒与宿主相互作用上.
主要方法:
- 对HPV E6和E7蛋白与宿主细胞蛋白相互作用的现有研究进行审查.
- 在HPV相关癌症发病和维持的背景下,分析已识别的宿主点.
- 与非病毒性癌症中的遗传突变驱动因素的比较.
主要成果:
- 许多宿主细胞蛋白已被确定为HPV E6和E7的潜在结合伙伴.
- 假设这些相互作用的子集对于驱动HPV致癌是关键的,类似于其他癌症的关键突变.
- 了解这些特定的相互作用对于治疗的发展至关重要.
结论:
- 优先确定致癌的E6和E7目标是必不可少的.
- 这种方法将增强对HPV在癌症中的作用的理解,并指导开发有效的抗癌疗法.
- 专注于关键的病毒与宿主相互作用将最大限度地提高治疗效果.
更多相关视频
13:41Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
12.4K
10:26RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
27.3K
相关概念视频
Cancer Prevention
6.1K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.1K
Mechanisms of Retrovirus-induced Cancers
5.1K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.1K
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Rous Sarcoma Virus (RSV) and Cancer
5.0K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.0K
Skin Cancer
4.0K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.0K
Viral Mutations
32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K
